Home IgG4-related hypophysitis in adolescence
Article
Licensed
Unlicensed Requires Authentication

IgG4-related hypophysitis in adolescence

  • Ved Bhushan Arya ORCID logo EMAIL logo , Sarra Abu El-Gasim , Sreena Das , Zita Reisz , Bassel Zebian , David D’Cruz , Andrew King , Tim Hampton , Simon J. B. Aylwin , Ritika R. Kapoor and Charles R. Buchanan
Published/Copyright: December 14, 2020

Abstract

Objectives

IgG4-related hypophysitis is a novel clinical disease entity, which is typically seen in the sixth decade of life and is typically complicated by hypopituitarism. We describe an adolescent female with IgG4-related hypophysitis with normal pituitary function and summarize the relevant literature.

Case presentation

A 11.8-year-old girl presented with headache and left VI cranial nerve palsy. MRI brain identified an enlarged pituitary gland. Endocrine investigations revealed normal pituitary function. She underwent a transsphenoidal biopsy of the pituitary gland, and histological examination confirmed the diagnosis of IgG4-related hypophysitis. Serum IgG4 concentrations were normal and no evidence of other organ involvement was found. Although the patient tested strongly positive for TB on an interferon gamma release assay, pituitary biopsy was negative for granuloma formation and acid-fast bacilli (Ziehl-Neelson staining). IgG4-related hypophysitis was treated with oral prednisolone and mycophenolate-mofetil with a good response.

Conclusions

We describe to the best of our knowledge, the youngest patient in the published literature with IgG4-related hypophysitis presenting without pituitary insufficiency. A literature review identified only five cases of IgG4-related hypophysitis in adolescence. Serum IgG4 concentrations were normal in all, except one of the adolescent patients reported so far, and appear unhelpful in diagnosis in this age group.


Corresponding author: Dr. Ved Bhushan Arya, Department of Paediatric Endocrinology, Variety Children Hospital, King’s College Hospital NHS Foundation Trust, LondonSE5 9RSUK, Phone: +44 (0) 2032993431, E-mail:

Acknowledgments

Nil.

  1. Research funding: Nil.

  2. Author contributions: All authors accept responsibility for the entire content of this submitted manuscript and approve submission. VBA conceptualised the idea of manuscript, collected the data and wrote the manuscript. SAE collected the data and reviewed the manuscript. BZ, DD’C, TH and SJBA were involved in patient management and critically reviewed the manuscript. SD, RK and CRB conceptualised the idea of manuscript and critically reviewed the manuscript. ZR and AK were involved in histological examination of the pituitary biopsy, prepared the figures for the manuscript and critically reviewed the manuscript. VBA is the guarantor of this work.

  3. Competing interests: The authors have no conflicts of interest to declare.

  4. Informed consent: Written informed consent was obtained from the parents of the patient for publication of this case report and any accompanying images.

References

1. Stone, JH, Zen, Y, Deshpande, V. IgG4-related disease. N Engl J Med 2012;366:539–51. https://doi.org/10.1056/nejmra1104650.Search in Google Scholar

2. van der Vliet, HJ, Perenboom, RM. Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis. Ann Intern Med 2004;141:896–7. https://doi.org/10.7326/0003-4819-141-11-200412070-00033.Search in Google Scholar

3. Leporati, P, Landek-Salgado, MA, Lupi, I, Chiovato, L, Caturegli, P. IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 2011;96:1971–80. https://doi.org/10.1210/jc.2010-2970.Search in Google Scholar

4. Li, Y, Gao, H, Li, Z, Zhang, X, Ding, Y, Li, F. Clinical characteristics of 76 patients with IgG4-related hypophysitis: a systematic literature review. Int J Endocrinol 2019;2019:5382640. https://doi.org/10.1155/2019/5382640.Search in Google Scholar

5. Bullock, DR, Miller, BS, Clark, HB, Hobday, PM. Rituximab treatment for isolated IgG4-related hypophysitis in a teenage female. Endocrinol Diabetes Metab Case Rep 2018;2018:18-0135. https://doi.org/10.1530/edm-18-0135.Search in Google Scholar

6. Liu, Y, Wang, L, Zhang, W, Pan, H, Yang, H, Deng, K, et al.. Hypophyseal involvement in immunoglobulin G4-related disease: a retrospective study from a single tertiary center. Int J Endocrinol 2018;2018:7637435. https://doi.org/10.1155/2018/7637435.Search in Google Scholar

7. Decker, L, Crawford, AM, Lorenzo, G, Stippler, M, Konstantinov, KN, SantaCruz, K. IgG4-Related hypophysitis: case report and literature review. Cureus 2016;8:e907. https://doi.org/10.7759/cureus.907.Search in Google Scholar

8. Peng, L, Zhang, P, Zhang, X, Li, J, Zhao, J, Liu, J, et al.. Clinical features of immunoglobulin G4-related disease with central nervous system involvement: an analysis of 15 cases. Clin Exp Rheumatol 2020;38:626–32.Search in Google Scholar

9. Pal, R, Chatterjee, D, Singla, R, Jain, N, Bhansali, A, Dutta, P. Co-occurrence of craniopharyngioma and IgG4-related hypophysitis: an epiphenomenon or a mere coincidence? World Neurosurg 2020;136:193–7. https://doi.org/10.1016/j.wneu.2019.12.181.Search in Google Scholar

10. Carruthers, MN, Stone, JH, Deshpande, V, Khosroshahi, A. Development of an IgG4-RD responder Index. Int J Rheumatol 2012;2012:259408. https://doi.org/10.1155/2012/259408.Search in Google Scholar

11. Shimizu, Y, Yamamoto, M, Yajima, H, Suzuki, C, Naishiro, Y, Takahashi, H, et al.. Role of interleukin-32 in the mechanism of chronic inflammation in IgG4-related disease and as a predictive biomarker for drug-free remission. Mod Rheumatol 2016;26:391–7. https://doi.org/10.3109/14397595.2015.1089973.Search in Google Scholar

Received: 2020-09-15
Accepted: 2020-11-05
Published Online: 2020-12-14
Published in Print: 2021-03-26

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review Article
  3. Inborn errors of immunity and metabolic disorders: current understanding, diagnosis, and treatment approaches
  4. Original Articles
  5. Evaluation of hydration status of children with obesity—a pilot study
  6. Relationship between insulin-like growth factor-1, insulin resistance and metabolic profile with pre-obesity and obesity in children
  7. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus
  8. Karyotype is associated with timing of ovarian failure in women with Turner syndrome
  9. The role of makorin ring finger protein-3, kisspeptin, and neurokinin B in the physiology of minipuberty
  10. Brain MRIs may be of low value in most children diagnosed with isolated growth hormone deficiency
  11. Significant improvement in bone mineral density in pediatric celiac disease: even at six months with gluten-free diet
  12. Population-based waist circumference reference values in Japanese children (0–6 years): comparisons with Dutch, Swedish and Turkish preschool children
  13. Extended growth charts for Indian children
  14. Rib fractures in infancy, case-series and register case-control study from Sweden
  15. Gonadotropin releasing hormone analogue therapy in girls with idiopathic precocious puberty/early-fast puberty: dynamics in adiposity indices, eating habits and quality of life
  16. Case Reports
  17. Transient benign hyperphosphatasemia due to COVID-19: the first case report
  18. ATP synthase deficiency due to m.8528T>C mutation – a novel cause of severe neonatal hyperammonemia requiring hemodialysis
  19. IgG4-related hypophysitis in adolescence
  20. Graves’ disease in a five-month-old boy with an unusual treatment course
  21. Oral sodium phenylbutyrate for hyperammonemia associated with congenital portosystemic shunt: a case report
  22. Severe multisystem organ dysfunction in an adolescent with simultaneous presentation of Addison’s and Graves’ disease
Downloaded on 4.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2020-0535/html
Scroll to top button